JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Paraurethral cyst in female newborn: is surgery always advocated?

AIM OF THE STUDY: Paraurethral cysts in females are rare, particularly in the neonatal period. Only 49 cases have been previously reported in English literature. The choice of management for this lesion remains controversial. Surgical management has been advocated, but spontaneous regression has also been reported. The aim of the study was to clarify the natural course of paraurethral cysts in female neonates and discuss the proper choice of treatment.

PATIENTS AND METHODS: Neonates who presented to our surgical unit with paraurethral cyst over a 5-year period (January 2000 through December 2005) were studied. The "nonoperative strategy" was indicated, and their clinical course and outcomes were examined.

RESULTS: Five consecutive patients with paraurethral cysts in female neonates were treated. There have been 5192 female births during the same period, and the incidence of paraurethral cyst was 1 in 1038 female births. None was associated with other anomalies. Clinical examination revealed interlabial cystic mass, which is spherical and yellowish in color, with dilated blood vessel on the anterior surface. It obscured both urethral meatus and vaginal orifice. However, there was no apparent voiding difficulty. These paraurethral cysts spontaneously disappeared at follow-up 76 to 304 days after birth.

CONCLUSION: Our data suggest that the number of reported case, being fewer than predicted, suggests that paraurethral cysts in female neonates are unrecognized. Paraurethral cysts are generally characterized by a completely asymptomatic lesion and have a high rate of spontaneously resolution. Thus, surgery (aspiration, marsupialization, or excision) should not be hurried, because natural resolution within a few months is the likely outcome.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app